Results 241 to 250 of about 37,820 (304)

The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma. [PDF]

Eur J Health Econ
Scortichini M, Mennini FS, Marcellusi A, Paoletti M, Tomino C, Sciattella P.   +5 more
europepmc   +1 more source

Genetic Contribution to Asthma Informs Acute Chest Syndrome Pathophysiology and Risk Stratification

American Journal of Hematology, Volume 101, Issue 5, Page 961-971, May 2026.
ABSTRACT Acute chest syndrome (ACS) is a severe complication of sickle cell disease (SCD) occurring in ~50% of patients, some presenting frequent episodes. We lack tools to identify patients at high risk of ACS occurrence or frequent episodes. Epidemiological studies have found an association between asthma and ACS, but whether this link is causal is ...
Sara El Aouhel, Vanessa Bellegarde, Stennio Da Silva Faria, Tristan St‐Laurent, Estelle Lecluze, Anne‐Laure Pham Hung d’Alexandry d’Orengiani, Frédéric Galactéros, Pablo Bartolucci, Marc‐André Legault, Guillaume Lettre, Thomas Pincez   +10 more
wiley   +1 more source

Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. [PDF]

J Clin Med
Menzella F, Marchi M, Caminati M, Romagnoli M, Micheletto C, Bonato M, Idotta G, Nizzetto M, D'Alba G, Cavenaghi M, Bortoli M, Beghè B, Pini L, Benoni R, Casoni G, Muzzolon R, Michieletto L, Bosi A, Mastrototaro A, Diamandi A, Nalin M, Senna G.   +21 more
europepmc   +1 more source

Beyond the Wheeze: Incidental Diagnosis of Eosinophilic Oesophagitis in a Young Child With Asthma‐Like Symptoms

Journal of Paediatrics and Child Health, EarlyView.
Sameena Tabassum, Keslar Just, Mili Jyotsna, Anayansi Lasso‐Pirot   +3 more
wiley   +1 more source

Less Can Be Enough: Sustained Remission of Pediatric Eosinophilic Esophagitis With Low‐Frequency Dupilumab

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Eosinophilic esophagitis (EoE) is a chronic, immune‐mediated disease requiring long‐term therapy. Dupilumab, an interleukin‐4 and interleukin‐13 receptor antagonist, is approved for EoE at a weekly 300 mg dosing regimen. However, data on reduced‐frequency dosing, especially in pediatric patients, remain limited.
Giovanni Scatigna, Annarita Iadecola, Martina Piersanti, Giovanni Di Nardo, Maurizio Mennini   +4 more
wiley   +1 more source

Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysis. [PDF]

Front Allergy
Blauwblomme M, Gevaert P, Van Nevel S, Riemann S, Vandewalle E, Holtappels G, De Ruyck N, Derycke L, Eeckels AS, Vanhee S, Lambrecht BN, Brusselle G, Van Zele T.   +12 more
europepmc   +1 more source

Bacterial biogeography of adult airways in atopic asthma [PDF]

, 2018
Beigelman, Avraham, Castro, Mario, et al,   +2 more
core   +1 more source

Incidental Detection of Asymptomatic Colonic Anisakiasis During Surveillance Colonoscopy: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Anisakiasis is a parasitic infection caused by ingestion of raw or undercooked seafood containing Anisakis larvae. Although gastric involvement is common, colonic anisakiasis is rare and may be asymptomatic, making diagnosis difficult without endoscopic evaluation.
Masashi Omori, Kenta Shibahara, Takashi Murakami, Eiji Kamba, Kei Nomura, Hirofumi Fukushima, Dai Ishikawa, Mariko Hojo, Tomoyoshi Shibuya, Akihito Nagahara   +9 more
wiley   +1 more source

Effects of benralizumab in patients with severe eosinophilic asthma (SEA): A plain language summary of the ANANKE study. [PDF]

Immunotherapy
Canonica GW, Consani L, Malerba L, Pelaia G, Vultaggio A, ANANKE investigators.   +5 more
europepmc   +1 more source